Clinical trials
Phase 2/3 Carcinoma, Hepatocellular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 8 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 26 |
| Completed | 10 |
| Recruiting | 10 |
| Terminated | 6 |
| Not yet recruiting | 5 |
| Withdrawn | 5 |
| Active, not recruiting | 3 |
| Suspended | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Guangxi Medical University | 6 |
| Eastern Hepatobiliary Surgery Hospital | 4 |
| All India Institute of Medical Sciences | 3 |
| Shanghai Zhongshan Hospital | 3 |
| Federation Francophone de Cancerologie Digestive | 2 |
| Fudan University | 2 |
| RenJi Hospital | 2 |
| Sun Yat-sen University | 2 |
| Zhejiang Cancer Hospital | 2 |
| Zhongda Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 67 |
| Liver Neoplasms | 10 |
| Fibrosis | 2 |
| Hepatitis B | 2 |
| Neoplasm Metastasis | 2 |
| Pancreatic Neoplasms | 2 |
| Recurrence | 2 |
| Adenocarcinoma | 1 |
| Bites and Stings | 1 |
| Breast Neoplasms | 1 |
Trials
Showing 26 to 50 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.